Q3 2026 BWX Technologies Earnings Conference Call Webcast - BWX TECHNOLOGIES INC

Financial Performance:

• Q3 2026 total revenue reached $953 million, representing a 10% year-over-year increase with 7% organic growth.
• Adjusted EBITDA grew 19% to $180 million, driven by double-digit growth in both Government Operations (22.6% margin) and Commercial Operations.
• Adjusted EPS increased 26% to $1.26, supported by higher operating income, lower interest expense, and a lower effective tax rate.
• Free cash flow for Q3 was $151 million; the company raised 2026 guidance for full-year FCF to a range of $350–$360 million.
• Capital expenditures are expected to remain steady at approximately 6% of revenue in 2026 and 2027, focused on capacity expansion and fuel scaling.

Guidance and Future Outlook:

• 2026 consolidated adjusted EBITDA is maintained at ~$667 million, with adjusted EPS guidance of $4.72–$4.77.
• 2027 preliminary outlook projects high single-digit to low double-digit growth in both adjusted EBITDA and EPS, aligning with the 2030 target path of $5.5–$6 billion revenue.
• Government Operations segment expects high single-digit to low double-digit revenue and EBITDA growth in 2027, fueled by special materials and naval propulsion.
• Commercial Operations anticipates high single-digit organic revenue growth (offset slightly by the planned medical divestiture) and an EBITDA margin improvement of 50–100 basis points.
• Management reaffirms confidence in achieving 2030 targets, driven by organic growth in core businesses and execution of new awards.

Business Segments and Product Lines:

• Government Operations: Revenue up 4% driven by Special Materials (HPDU ramp-up and HEU enrichment facility design) and Technical Services (AI adoption, Y-12 lithium facility conceptual design). Naval propulsion secured an $189M annual fuel contract.
• Advanced Nuclear: Completed Project Pele core barrel; secured U.S. Army Janus program for micro-reactors at five bases; won the "Banner" award for Prodigy Clean Energy's New Brunswick project (first international micro-reactor win); signed multi-year TRISO fuel supply agreement with Antares.
• Commercial Operations: Revenue surged 25% (15% organic), boosted by the PCG acquisition. Completed 50% capacity expansion at the Cambridge facility; final investment decision pending for a new U.S. heavy component manufacturing facility.
• Product Specifics: HPDU construction initiated in Jonesboro, Tennessee; TRISO fuel production at Lynchburg, Virginia, is being scaled to quadruple near-term output.

Market and Competitive Landscape:

• Global nuclear demand is described as accelerating from a "trickle to a flood," driven by energy security and decarbonization goals in the U.S., Europe (specifically Poland), and Canada.
• Micro-reactors (Banner) are positioned ahead of large reactor new builds in terms of commercial order conversion, with the 20MW electrical output differentiating BWXT's product from competitors.
• Market interest in CANDU reactors in the U.S. presents potential export opportunities for BWXT as a supply chain partner.
• SMR projects are expected to precede large reactor projects (e.g., TVA, AP1000) in the order book timeline.

Risks and Challenges:

• Risk Allocation: The primary gating item for new large-reactor projects (FID) is not financing but the allocation of risk between utilities, hyperscalers, and the government.
• Capacity Constraints: While current capacity is being expanded (Cambridge expansion, U.S. facility, PCG integration), managing the scaling of new programs (HPDU, Special Materials) without margin dilution is a focus.
• Working Capital: Anticipated working capital investments and pension contribution headwinds (~$10M) may impact cash flow timing in 2027.
• Market Execution: Success depends on converting a robust pipeline of opportunities into firm contracts, particularly in the commercial sector.

Management Commentary and Tone:

• Tone is highly confident and optimistic, emphasizing strong execution, operational excellence, and a "predictable core" underpinned by significant organic growth.
• Management highlighted the "bipartisan political support" for nuclear energy as a stabilizing factor against political gridlock.
• CFO emphasized a disciplined capital allocation strategy, prioritizing organic investments and acquisitions that do not hinder the 2030 financial targets, with share repurchases contingent on capital availability.
• CEO reiterated that long-term value creation relies on converting opportunities into profitable growth and strong cash generation.

Analyst Questions and Answers:

• Margins: Government Operations margins benefited from efficiency gains in naval nuclear business; Special Materials programs are in early stages with lower initial margins.
• Capital Allocation: $3–$4B of additional spending is required by 2030; this is primarily for organic capacity (Special Materials, micro-reactors) beyond the 5–6% core CapEx. M&A is optional to hit targets but remains a priority if high-quality targets emerge.
• PCG Acquisition: Integration is on track with ~$500M in backlog absorbed; the acquisition provides access to underutilized capacity for commercial work.
• Facility Decisions: U.S. heavy component facility will proceed without requiring firm orders first, unlike the Poland project which requires firm orders to justify investment.
• Commercial Timing: Management expects new U.S. reactor plant build orders by late 2026 or H1 2027, with SMR activity leading the sequence.
• Political Environment: Midterm elections and continuing resolutions are not expected to materially impact forecasts due to the "program of record" nature of most government contracts.
• New Build Risk: Component manufacturing risk (RPVs, steam generators) is viewed as manageable; major risks lie in project delivery and risk allocation rather than fabrication capability.

Other Key Points:

• BWXT received an inaugural investment-grade rating from Fitch and a positive outlook revision from Moody's.
• The PCG acquisition closed in early July, contributing significantly to Q3 commercial revenue.
• A medical business divestiture is on track to close later in 2026, impacting 2027 commercial revenue guidance but improving margin mix.
• Technical Services teams are integrating AI to drive site performance and efficiency.
• The "Banner" micro-reactor is a 20MW electrical output unit, offering higher utility than competitors' smaller megawatt-range reactors while remaining rail-shippable.